Only 3 tumor-reactive circulating CD8 T cell lines showed responses, which were limited to two CTA (PLAC1 and ACTL8) overlapping peptide pools, reiterating the challenge of finding relevant breast cancer antigens (Figure 2G). This evidence concerns the gene ACTL8 and breast carcinoma.